Pictured: Marcel R. M. van den Brink
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, December 21, 2012

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Pictured: X-ray Image
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, December 19, 2012

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Steven Wang
Q&A
By Andrea Peirce, BA, Writer/Editor  |  Monday, December 17, 2012

By mid-December 2012, sunscreen products on store shelves in the United States must meet stricter labeling regulations. Dr. Wang answers key questions on this topic.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Ethel Law & Elizabeth Grahn
Announcement
By Media Staff  |  Monday, December 10, 2012

Memorial Sloan Kettering advanced practice nurses Elizabeth Grahn and Ethel Law have been recognized for their extraordinary achievements in education and research.

Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Pictured: 2012 Rock Stars of Science
Announcement
By Allyson Collins, MS, Science Writer/Editor  |  Thursday, December 6, 2012

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Pictured: Clifford Hudis
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, December 5, 2012

New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.

Feature
By Memorial Sloan Kettering  |  Monday, December 3, 2012

Memorial Sloan Kettering physicians and nurses take their knowledge and expertise overseas.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: Carol Brown
Video
By Memorial Sloan Kettering  |  Wednesday, November 28, 2012

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

Q&A
By Media Staff  |  Wednesday, November 21, 2012

Cancer patients use more blood and platelets than patients with any other illness. Memorial Sloan Kettering is always in need of blood donations – especially during the holiday season.

In the News
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 16, 2012

Memorial Sloan Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.